Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (HEPA)

Historical Holders from Q3 2019 to Q2 2023

Symbol
HEPA on Nasdaq
CUSIP
426897104
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
11.8M
All holders as of June 30, 2023
Q2 2023
Total 13F shares, excl. options
0
Holdings value
$0
Number of holders
0
Number of sells
-6
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (HEPA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Anson Funds Management LP 4.9% -50% 576K -3.23% Anson Funds Management LP Jun 30, 2025

Institutional Holders of Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (HEPA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2023 Q2 0 $0 -$56K 0
2023 Q1 72.2K $56K +$3.00 $1.00 6
2022 Q4 277K $137K +$18.9K $0.47 6
2022 Q3 7.14M $3.61M -$219K $0.51 24
2022 Q2 7.4M $4.24M -$120K $0.57 26
2022 Q1 7.55M $9.73M -$281K $1.29 30
2021 Q4 7.9M $9M -$8.23K $1.14 38
2021 Q3 7.79M $11.9M -$5.02M $1.53 34
2021 Q2 10.7M $21.2M +$5.87M $1.98 40
2021 Q1 7.97M $14.7M +$3.9M $1.84 38
2020 Q4 5.46M $12M +$9.22M $2.19 27
2020 Q3 268K $832K +$410K $3.10 13
2020 Q2 141K $403K -$182K $2.87 5
2020 Q1 208K $367K -$227K $1.76 5
2019 Q4 179K $957K +$516K $5.36 11
2019 Q3 156K $377K +$377K $2.43 4